
Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).
Wardlow is an infectious diseases clinical pharmacist at the Ohio State University Wexner Medical Center. She also serves as the health-system’s program director for the PGY2 infectious diseases residency.
Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).